Abstract
We had a 72-year-old man with advanced gastric cancer, poorly differentiated adenocarcinoma, receiving chemotherapy with S-1 (tegafur, gimeracil, and oteracil potassium) plus oxaliplatin. Ascites developed despite remission of gastric cancer and metastasis. Given no malignant cells in ascites, leg edema, renal impairment, hypoalbuminemia, and massive proteinuria, we diagnosed as nephrotic syndrome with microscopic hematuria. Renal biopsy showed membranoproliferative glomerulonephritis with no deposition of immunoglobulins and complements. Of note, electronic microscopy found organized deposits with microtubular structures in the glomerular capillary lumens and subendothelial spaces. The liquid chromatography-tandem mass spectrometry method detected fibrinogen alpha chain, beta chain, gamma chain, and fibronectin, and we eventually diagnosed cryofibrinogen-associated glomerulonephritis. Cryofibrinogen was not detected in plasma. He was expired at 5 months following renal biopsy due to the progression of refractory nephrotic syndrome. In addition to the detailed assessment of specifically organized deposits, the analysis using liquid chromatography-tandem mass spectrometry method is useful to diagnose cryofibrinogen-associated glomerulonephritis. We should consider cryofibrinogen-associated glomerulonephritis as a differential diagnosis when the patients with malignancy showed abnormal urinalysis and renal impairment, though it is a rare disease.
Similar content being viewed by others
References
Korst DR, Kratochvil CH. Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans. Blood. 1955;10:945–53.
Moiseev S, Luqmani R, Novikov P, Shevtsova T. Cryofibrinogenaemia-a neglected disease. Rheumatology. 2017;56:1445–51.
Sethi S, Yachoui R, Murray DL, Radhakrishnan J, Alexander MP. Cryofibrinogen-associated glomerulonephritis. Am J Kidney Dis. 2017;69:302–8.
Cambier JF, Ronco P. Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol. 2012;7:1701–12.
Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int. 2013;84:34–44.
Dahabreh I, Tsoutsos G, Tseligas D, Janinis D. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report. BMC Clin Pharmacol. 2006;6:5.
Saadoun D, Elalamy I, Ghillani-Dalbin P, Sene D, Delluc A, Cacoub P. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med. 2009;122:1128–35.
Blain H, Cacoub P, Musset L, Costedoat-Chalumeau N, Silberstein C, Chosidow O, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120:253–60.
Soyfoo MS, Goubella A, Cogan E, Wautrecht JC, Ocmant A, Stordeur P. Clinical significance of cryofibrinogenemia: possible pathophysiological link with Raynaud’s phenomenon. J Rheumatol. 2012;39:119–24.
Belizna C, Loufrani L, Subra JF, Godin M, Jolly P, Vitecocq O, et al. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmun Rev. 2011;10:559–62.
Terrier B, Izzedine H, Musset L, Ghillani P, Deray G, Saadoun D, et al. Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders. Nephrol Dial Transplant. 2011;26:3577–81.
Nash JW, Ross P Jr, Neil Crowson A, Taylor J, Morales JE, Yunger TM, et al. The histopathologic spectrum of cryofibrinogenemia in four anatomic sites. Skin, lung, muscle, and kidney. Am J clin pathol. 2003;119:114–22.
Singh A, Gaber LW. Nephrotic syndrome and chronic renal insufficiency associated with essential cryofibrinogenemia. Nephrol Dial Transplant. 2007;22:1772–5.
Sudo M, Sakamaki Y, Hosojima M, Yamamoto S, Ito Y, Imai N, et al. Cryofibrinogen-associated glomerulonephritis diagnosed by mass spectrometry and immunoelectron microscopy. Hum Pathol Case Rep. 2019;15:83–7.
Ibuki E, Shiraishi A, Sofue T, Kushida Y, Kadota K, Honda K, et al. Characteristic electron-microscopic features of cryofibrinogen-associated glomerulonephritis: a case report. BMC Nephrol. 2020;21:27.
Stathakis NE, Karamanolis D, Koukoulis G, Tsianos E. Characterization of cryofibrinogen isolated from patients plasma. Haemostasis. 1981;10:195–202.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Ethical approval
All procedures performed in this case were in accordance with the ethical standards of the 1964 Helsinki declaration.
Informed consent
Informed consent was obtained from the patient for the publication of this case report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kakeshita, K., Yamazaki, H., Imamura, T. et al. Cryofibrinogen-associated glomerulonephritis accompanied by advanced gastric cancer. CEN Case Rep 10, 527–536 (2021). https://doi.org/10.1007/s13730-021-00602-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-021-00602-0